- Home
- HLP vs DRRX Comparison
HLP vs DRRX Comparison
Compare HLP & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- DRRX
- Stock Information
- Founded
- HLP 2021
- DRRX 1998
- Country
- HLP China
- DRRX United States
- Employees
- HLP N/A
- DRRX N/A
- Industry
- HLP Industrial Machinery/Components
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- HLP Industrials
- DRRX Health Care
- Exchange
- HLP Nasdaq
- DRRX Nasdaq
- Market Cap
- HLP 52.1M
- DRRX 59.3M
- IPO Year
- HLP 2023
- DRRX 2000
- Fundamental
- Price
- HLP $0.69
- DRRX $1.95
- Analyst Decision
- HLP
- DRRX Hold
- Analyst Count
- HLP 0
- DRRX 1
- Target Price
- HLP N/A
- DRRX N/A
- AVG Volume (30 Days)
- HLP 207.2K
- DRRX 557.2K
- Earning Date
- HLP 09-18-2025
- DRRX 08-12-2025
- Dividend Yield
- HLP N/A
- DRRX N/A
- EPS Growth
- HLP N/A
- DRRX N/A
- EPS
- HLP N/A
- DRRX N/A
- Revenue
- HLP $14,105,620.00
- DRRX $1,657,000.00
- Revenue This Year
- HLP N/A
- DRRX N/A
- Revenue Next Year
- HLP N/A
- DRRX $673.00
- P/E Ratio
- HLP N/A
- DRRX N/A
- Revenue Growth
- HLP N/A
- DRRX N/A
- 52 Week Low
- HLP $0.61
- DRRX $0.48
- 52 Week High
- HLP $2.13
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- HLP 48.54
- DRRX 81.88
- Support Level
- HLP $0.66
- DRRX $1.86
- Resistance Level
- HLP $0.68
- DRRX $1.95
- Average True Range (ATR)
- HLP 0.05
- DRRX 0.04
- MACD
- HLP 0.01
- DRRX -0.04
- Stochastic Oscillator
- HLP 40.08
- DRRX 86.36
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.